Tyme Technologies, Inc. (TYME)


Tyme Technologies, Inc. (TYME)

$1.23 USD

0.03 (-2.38%)

Updated Jul 19 12:00am

Add TYME to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

TYME Daily Price Range
TYME 52-Week Price Range

TYME News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All TYME News

Tyme Technologies, Inc. (TYME) Company Bio


Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. It is developing SM-88, a combination therapy in Phase II development for prostate cancer. The company was founded in 2011 and is based in New York, New York.

TYME Stock Chart More Charts


TYME Price/Volume Stats

Current price $1.23
Prev. close $1.26
Day low $1.23
Day high $1.26
50-day MA $1.24
200-day MA $2.20
52-week high $4.64
52-week low $0.92
Volume 298,900
Avg. volume 775,654
Dividend yield N/A
Market Cap 137.70M

TYME Social Stream


Loading social stream, please wait...

View Full TYME Social Stream

TYME Returns

1-mo 20.59%
3-mo -18.54%
6-mo -43.58%
1-year -57.73%
3-year -87.05%
5-year N/A
YTD -66.67%
2018 -42.16%
2017 70.13%
2016 N/A
2015 N/A
2014 N/A


Page generated in 0.3855 seconds.